Human Insulin

The Sanand facility will be designed and implemented for supplying products to India, EU, US and across the global market. The process operations and equipment shall be designed in accordance with guidelines of WHO, PIC/s, EMA, US FDA and Schedule M. DS Manufacturing suite at 5000 L Fermenter (Working Volume) scale with Production capacity of 330 Kg DS at Phase 1 and add on 120 KG at Phase 2. Drug Product Facility shall be equipped with Primary packaging machines, secondary and tertiary packaging machines with capacity of producing 20Million cartridges and 6 Million Vials per annum.